C2i & Hitachi To Collaborate On Automation Of Organoids Cell Culture & Mass Production of Exosomes

LATEST NEWS

Sep 5

Antibody Fc receptor binding and T cell responses to homologous and heterologous immunization with inactivated or mRNA vaccines against SARS-CoV-2

A recent study from C2i with the HKU-Pasteur Research Pole and the School of Public Health (HKU)published in Nature Communications...

Aug 7

[Hiring] Post-doctoral Fellow Job (C2i096-P3)

Reference Number: (C2i096-P3) The Centre for Immunology & Infection (C2i) uses novel technology platforms for biomarker discovery and the...

Aug 1

[Call for Application] HKU-Pasteur 11th Immunology Course

This year, the Centre for Immunology & Infection will be co-organising the 11th HKU-Pasteur Research Pole Immunology Course with a world...

About

ABOUT C2i

The Centre for Immunology & Infection (C2i) uses novel technology platforms for biomarker discovery and the development of new vaccine and therapeutic strategies.

C2i is the fruit of a long-standing partnership of more than 20 years between the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) and the Institut Pasteur, two major institutions combining their expertise to establish this centre of excellence.